Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With High Risk Coronary Artery Disease (FORWARD)
Clinical trial NCT04087915 · UNKNOWN
Trial details
- NCT number
- NCT04087915
- Sponsor
- Beijing Anzhen Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-11
- Primary completion
- 2021-12-31
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.